UK-based medical technology firm York Instruments has partnered with Germany-based medical device manufacturer eemagine Medical Imaging Solutions to develop integrated solutions with magnetoencephalography (MEG) and electroencephalography (EEG).
The firms intend to study human electromagnetic brain activity using the MEG-EEG instrumentation and software for research and clinical diagnostics purposes.
The partnership is expected to facilitate York Instruments to offer users a high-resolution EEG measurements and clinical analysis software.
York Instruments president James Petite said: "We are convinced this cooperation will benefit both parties in their efforts to accelerate the development of new and exciting MEG applications that meet even the most advanced requirements in neuroscience and clinical use."
The MEG and EEG are non-invasive measurement techniques designed for the detailed study of neuronal activity in the human cortex.
The combination of these techniques is claimed to be effective for routine clinical use and can be used for presurgical evaluation of epilepsy patients, in addition to study of neurodegenerative disorders such as Alzheimer's.
eemagine chief executive officer Frank Zanow said: "Our company has a long history in MEG analysis software and vast expertise using EEG data with our ASA software and eego EEG amplifier line, as brought to the market by ANT Neuro, a leading supplier in neuroscience."
York Instruments has further included ANT Neuro's MEGSCAN clinical software package and EEG amplifier components in the MEGSCAN product offering.
Founded in 1999, eemagine Medical Imaging Solutions manufactures products for neuroscience, neurodiagnostics and neuromodulation, while York Instruments develops magnetic measurements and new technologies for neuroimaging.